Characterizing clinically significant prostate cancer using template prostate mapping biopsy

Journal of Urology

Volumn 186, Issue 2, 2011, Pages 458-464

  Ahmed, Hashim Uddin ^a   Hu, Yipeng ^a   Carter, Tim ^a   Arumainayagam, Nimalan ^a   Lecornet, Emilie ^d   Freeman, Alex ^b   Hawkes, David ^a   Barratt, Dean C ^a   Emberton, Mark ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

biopsy; computer simulation; prostate; prostatic neoplasms; ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SIMULATION; TRANSPERINEAL PROSTATE MAPPING BIOPSY; TUMOR VOLUME;

ADULT; AGED; BIOPSY, NEEDLE; COMPUTER SIMULATION; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 79960185825     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.147     Document Type: Article

References (22)

1. N.J. van As, and C.C. Parker Active surveillance with selective radical treatment for localized prostate cancer Cancer J 13 2007 289
2. G. Onik, M. Miessau, and D.G. Bostwick Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management J Clin Oncol 27 2009 4321
3. V. Scattoni, A. Zlotta, and R. Montironi Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature Eur Urol 52 2007 1309
4. G.R. Kepner, and J.V. Kepner Transperineal prostate biopsy: analysis of a uniform core sampling pattern that yields data on tumor volume limits in negative biopsies Theor Biol Med Model 7 2010 23
5. M. Karavitakis, H.U. Ahmed, and N. Livni The role of tumor focality in prostate cancer for the selection of patients for focal therapy J Urol 181 2009 491
6. S.R. Bott, H.U. Ahmed, and R.G. Hindley The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer BJU Int 106 2010 1607
7. T.A. Stamey, F.S. Freiha, and J.E. McNeal Localized prostate cancer Relationship of tumor volume to clinical significance for treatment of prostate cancer Cancer 71 1993 933
8. J.I. Epstein, P.C. Walsh, and M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
9. M. Loughlin, I. Carlbom, and C. Busch Three-dimensional modeling of biopsy protocols for localized prostate cancer Comput Med Imaging Graph 22 1998 229
10. N.M. Alpert, J.F. Bradshaw, and D. Kennedy The principal axes transformationa method for image registration J Nucl Med 31 1990 1717
11. S.P. Raya, and J.K. Udupa Shape-based interpolation of multidimensional objects IEEE Trans Med Imaging 9 1990 32
12. S. Jonmarker, A. Valdman, and A. Lindberg Tissue shrinkage after fixation with formalin injection of prostatectomy specimens Virchows Arch 449 2006 297
13. E.D. Crawford, S.S. Wilson, and K.C. Torkko Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy BJU Int 96 2005 999
14. T. Wolters, M.J. Roobol, and P.J. Leeuwen A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial J Urol 185 2011 121
15. H.U. Ahmed, A. Kirkham, and M. Arya Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 6 2009 197
16. J.R. Stark, S. Perner, and M.J. Stampfer Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Onc 27 2009 3459
17. L. Esserman, Y. Shieh, and I. Thompson Rethinking screening for breast cancer and prostate cancer JAMA 302 2009 1685
18. L. Klotz, L. Zhang, and A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
19. R. Mazzucchelli, I. Nesseris, and L. Cheng Active surveillance for low-risk prostate cancer Anticancer Res 30 2010 3683
20. H.U. Ahmed The index lesion and the origin of prostate cancer N Engl J Med 361 2009 1704
21. J. de la Rosette, H.U. Ahmed, and J. Barentsz Focal therapy in prostate cancer-report from a consensus panel J Endourol 24 2010 775
22. D.G. Bostwick, D.J. Waters, and E.R. Farley Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006 Urology 70 2007 42